BRYAN BALL - 01 Mar 2025 Form 4 Insider Report for Aadi Bioscience, Inc. (WHWK)

Signature
/s/ Stephen Rodin, as Attorney-in-Fact
Issuer symbol
WHWK
Transactions as of
01 Mar 2025
Net transactions value
+$234,955
Form type
4
Filing time
04 Mar 2025, 18:09:52 UTC
Previous filing
26 Apr 2024
Next filing
03 Apr 2025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AADI Common Stock Options Exercise +5,000 +5% 105,000 01 Mar 2025 Direct F1
transaction AADI Common Stock Sale $5,045 -2,147 -2% $2.35 102,853 03 Mar 2025 Direct F2
transaction AADI Common Stock Award $240,000 +100,000 +97% $2.40 202,853 04 Mar 2025 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AADI Restricted Stock Units Options Exercise $0 -5,000 -25% $0.000000 15,000 01 Mar 2025 Common Stock 5,000 Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit ("RSU") represents a contingent right to receive one share of Aadi Bioscience, Inc. Common Stock.
F2 Represents a broker-assisted sale to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of restricted stock units.
F3 Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, twenty five percent (25%) of the shares subject to the award shall vest on the one-year anniversary of the Vesting Commencement Date, and twenty five percent (25%) of the shares subject to the award shall vest each of the next three Vesting Commencement Date anniversaries thereafter. "Vesting Commencement Date" shall mean March 1, 2024.

Remarks:

Chief Technical Operations Officer and SVP, Manufacturing Operations